Discover
KAPA
Kairos Pharma, Ltd.
0.39
1 x 0.38
20 x 0.39
bid
ask
-
0.00
1.03%
10 @ 04:00 PM
0.39 +0.00 (0.44%)
| Ytd | -45.63% | |
| 1y | -59.79% |
0.37
day range
0.41
0.27
52 week range
2.11
| Open | 0.40 | Prev Close | 0.39 | Low | 0.37 | High | 0.41 | Mkt Cap | 8.26M |
| Vol | 612.23K | Avg Vol | 2.19M | EPS | -0.30 | P/E | -1.29 | Forward P/E | -7.46 |
| Beta | 1.56 | Short Ratio | 0.13 | Inst. Own | 0.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.38 | 200-d Avg | 0.62 | 1yr Est | 9.00 |
| Income Statement | |||
| Operating Expenses | 1.69M | ||
| Research and Development Expense | 684.00K | ||
| Selling, General and Administrative Expense | 1.01M | ||
| Operating Income | -1.69M | ||
| Net Income | -1.65M | ||
| Net Income Common Stock | -1.65M | ||
| Net Income Common Stock (USD) | -1.65M | ||
| Consolidated Income | -1.65M | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | -1.65M | ||
| Earning Before Interest & Taxes (USD) | -1.65M | ||
| Weighted Average Shares | 21.01M | ||
| Weighted Average Shares Diluted | 21.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.68M | ||
| Cash and Equivalents (USD) | 3.68M | ||
| Current Assets | 4.44M | ||
| Total Assets | 5.74M | ||
| Current Liabilities | 431.00K | ||
| Total Liabilities | 431.00K | ||
| Accumulated Retained Earnings (Deficit) | -15.92M | ||
| Shareholders Equity | 5.31M | ||
| Shareholders Equity (USD) | 5.31M | ||
| Assets Non-Current | 1.30M | ||
| Goodwill and Intangible Assets | 22.00K | ||
| Trade and Non-Trade Payables | 431.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 40.00K | ||
| Net Cash Flow from Financing | 220.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -816.00K | ||
| Issuance (Purchase) of Equity Shares | 385.00K | ||
| Net Cash Flow from Operations | -1.04M | ||
| Share Based Compensation | 259.00K | ||